Jiang Zhu

Dr. Jiang Zhu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2018 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
CXChaoli Xu
Chaoli Xu
ZTZhaogang Teng
Zhaogang Teng
YZYunlei Zhang
Yunlei Zhang
Lihui YuwenLihui Yuwen
Lihui Yuwen
QZQi Zhang
Qi Zhang
JZJiang Zhu
Jiang Zhu

6 August 2023 in World Journal of Clinical Cases
Verified
Journal Article
Open access
HDHe-Qin Dong
He-Qin Dong
XFXiao-Feng Fu
Xiao-Feng Fu
MWMin-Yan Wang
Min-Yan Wang
JZJiang Zhu
Jiang Zhu
In recent years, because of the growing desire to improve the noninvasiveness and safety of tumor treatments, sonodynamic therapy has gradually become a popular research topic. However, due to the complexity of the therapeutic process, the relevant mechanisms have not yet been fully elucidated. One of the widely accepted possibilities involves the effect of reactive oxygen species. In this review, the mechanism of reactive oxygen species production by sonodynamic therapy (SDT) and ways to enhance the sonodynamic production of reactive oxygen species are reviewed. Then, the clinical application and limitations of SDT are discussed. In conclusion, current research on sonodynamic therapy should focus on the development of sonosensitizers that efficiently produce active oxygen, exhibit biological safety, and promote the clinical transformation of sonodynamic therapy.

30 November 2023 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
HLHuan Liu
Huan Liu
XHXiuli Huang
Xiuli Huang
WCWei Chen
Wei Chen
LDLei Ding
Lei Ding
YRYiming Ren
Yiming Ren
JZJiang Zhu
Jiang Zhu
N/O co-doped graphitic hierarchical porous carbon is yielded from wasted polymers. A capacity of 257.9 mA h g−1 with an ultrahigh energy density of 226.5 W h kg−1 is delivered. Excellent energy storage ability is also obtained for wearable devices.

8 May 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YZYadan Zhou
Yadan Zhou
WFWei Feng
Wei Feng
XQXiaoqin Qian
Xiaoqin Qian
LYLuodan Yu
Luodan Yu
XHXiuguo Han
Xiuguo Han
JZJiang Zhu
Jiang Zhu

1 May 2006
Verified
Conference Paper
Closed access
PTPiyush Thakre
Piyush Thakre
DLDimitris Lagoudas
Dimitris Lagoudas
JZJiang Zhu
Jiang Zhu
EBEnrique Barrera
Enrique Barrera
TGThomas Gates
Thomas Gates

29 April 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
GFGonglin Fan
Gonglin Fan
JQJiale Qin
Jiale Qin
XFXiaofeng Fu
Xiaofeng Fu
XSXing Si
Xing Si
LLLiqiang Li
Liqiang Li
JZJiang Zhu
Jiang Zhu
Ultrasound targeted microbubble destruction (UTMD) was introduced as a promising method to improve anti-tumor therapeutic efficacy, while minimizing side effects to healthy tissues. Nevertheless, the acoustical phenomenon behind the UTMD as well as the exact mechanisms of autophagy action involved in the increased anti-cancer response are still not fully understood. Therefore, we examined the drug resistance-reversing effects of low-intensity focused ultrasound with microbubble (LIFU+MB) in paclitaxel (PTX)-resistant ovarian cancer cells. Cell viability was evaluated using CCK8 (Cell Counting Kit-8), apoptosis was detected by flow cytometry, quantitative real-time PCR and Western blot were used to detect the expressions of mRNA and protein, and autophagy was observed by transmission electron microscopy (TEM). We revealed that the level of autophagy was increased (p < 0.05) in PTX-resistant ovarian cancer cells. Treatment of LIFU+MB combined with PTX can notably inhibit proliferation as well as increase apoptosis (p < 0.01) in drug-resistant cells. We proposed that LIFU+MB might affect the sensitivity of ovarian cancer cells to PTX by modulating autophagy. To verify the hypothesis, we analyzed the autophagy level of drug-resistant cells after the treatment of LIFU+MB and found that autophagy was significantly inhibited. Altogether, our findings demonstrated that LIFU+MB could reverse PTX resistance in ovarian cancer via inhibiting autophagy, which provides a novel strategy to improve chemosensitivity in ovarian cancer.